SigmaGraft
SigmaGraft Biomaterials is a privately held U.S. manufacturer of dental and orthopedic biomaterials — bone grafts, resorbable membranes, synthetic bioceramics, and wound dressings — sold in more than 60 countries to clinicians through distribution, e-commerce, and contract manufacturing.
- Company typePrivate
- Founded2010
- HeadquartersFullerton, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What SigmaGraft does
SigmaGraft Biomaterials, Inc. is a privately held U.S. manufacturer of dental and orthopedic biomaterials, founded in 2010 and operating from Brea, California (corporate headquarters at 450 Apollo St Ste B) and Fullerton, California (manufacturing facility at 575 Sally Place). The company designs, produces, and distributes bone graft substitutes, resorbable collagen membranes, synthetic bioceramics, wound dressings, and sutures used in guided bone regeneration (GBR), guided tissue regeneration (GTR), dental implantology, periodontal surgery, spinal fusion, and orthopedic trauma. Its portfolio spans allograft (SigmaOss), xenograft (InterOss), bone-collagen composites (InterOss Collagen), biphasic and tricalcium phosphate ceramics (BoneSigma BCP/TCP), resorbable collagen membranes (InterCollagen Guide), DBM products (AlloGen), active bone graft substitutes for spine (ExcellBone Active), sports medicine/trauma grafts (MaximOss), and wound dressings (SigmaPlug, SigmaTape).
Underlying technology centers on biomaterial scaffolds with controlled porous architecture (e.g., InterOss macropores of 40–60 μm and micro-channels ≤1.5 μm) designed to mimic natural trabecular bone and support osteoconduction. Manufacturing is vertically integrated in ISO Class 7 cleanroom environments under ISO 13485 certification, enabling both proprietary product lines and contract manufacturing services for other medical device companies.
SigmaGraft monetizes through one-time product sales across three channels: a direct e-commerce storefront (shop.sigmagraft.com), a dedicated customer service sales team, and a global distribution network serving more than 60 countries. The company also offers contract manufacturing for third-party dental, spine, and orthopedic device companies. Customer education and clinical faculty relationships (e.g., SigmaGraft Bone & Tissue Regeneration CE course, VISTA Institute programs) function as a marketing and brand-building layer rather than a direct revenue stream. Pricing is quote-based and not publicly disclosed; no revenue figures, funding rounds, or ownership disclosures are available in the source data, indicating an independent, likely founder-controlled private company.
SigmaGraft firmographics
Firmographics- Name
- SigmaGraft
- Legal name
- SigmaGraft Biomaterials, Inc.
- Website
- https://sigmagraft.com
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- SigmaGraft Biomaterials is a privately held U.S. manufacturer of dental and orthopedic biomaterials — bone grafts, resorbable membranes, synthetic bioceramics, and wound dressings — sold in more than 60 countries to clinicians through distribution, e-commerce, and contract manufacturing.
- Ownership category
- akta.pro rank
SigmaGraft industry classification
Industry- Product category
- Medical Device Biomaterials
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113), Dental Equipment and Supplies Manufacturing (339114), Biological Product (except Diagnostic) Manufacturing (325414), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (42345)
- SIC
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Biological Products, (No Disgnostic Substances) (2836), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM) (HLAHAEAG)
- akta.pro secondary industries
- Cartilage, Bone & Musculoskeletal Regeneration (HLAAAGAH), Tissue-Engineered Constructs & Scaffolds (natural/synthetic biomaterials) (HLAAAGAB), Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts) (HLAHALAE), Implant Prosthetics & Abutment Fabrication (HLABAJAC)
Keywords
Where SigmaGraft is headquartered
LocationHeadquarters
- HQ city
- Fullerton
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
SigmaGraft business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Biomaterial Products: Sale of bone graft substitutes, collagen membranes, wound dressings, and related medical devices for dental and orthopedic applications. Products are sold directly through e-commerce and distribution network.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Medical device biomaterial products - pricing available upon request |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels5 records
SigmaGraft product offering
Product offeringCore offering
SigmaGraft manufactures and sells biomaterial products for bone and tissue regeneration, including allograft and xenograft bone substitutes, bone-collagen composites, synthetic biphasic and tricalcium phosphate bioceramics, resorbable collagen membranes, wound dressings, and surgical sutures. These products are used by dental professionals and orthopedic surgeons for guided bone regeneration, ridge preservation, dental implant placement, sinus augmentation, periodontal defect treatment, spinal fusion, trauma surgery, and sports medicine. The company also offers contract manufacturing services to other medical device companies using its ISO Class 7 facilities.
Product overview
SigmaGraft Biomaterials is a manufacturer of biomaterials for dental and orthopedic surgeries specializing in bone and tissue regeneration products. The product portfolio includes allograft bone substitutes (SigmaOss™), xenograft bone grafts (InterOss®), bone-collagen composites, biphasic and tricalcium phosphate ceramics (BoneSigma™), resorbable collagen membranes (InterCollagen® Guide), wound dressings (SigmaPlug™, SigmaTape™), demineralized bone matrix (AlloGen™ DBM), and sutures. The company operates in dental (bone grafting, tissue regeneration, wound care) and orthopedic (spine, sports medicine/trauma) segments, selling products in over 60 countries worldwide.
Differentiator
Problem solved
Functional benefit
Brands
- InterOss: Anorganic cancellous bone graft granules derived from bovine source, featuring naturally interconnected porous architecture for osteoconductive scaffold in guided bone regeneration.
- InterOss Collagen
- InterCollagen Guide
- SigmaOss
- BoneSigma
- AlloGen
- ExcellBone Active
- SigmaPlug
- SigmaTape
Products and services
- SigmaOss™
Quantifiable outcome
- Products registered and sold in more than 60 countries worldwide
Companies that use SigmaGraft
Customer profileNamed customers8 records
Segments3 records
Ideal customer profiles3 records
SigmaGraft technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
SigmaGraft partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- Leading Universities (Research Collaborations)coreSigmaGraft has established close partnerships with several leading universities for research and development. These collaborations provide access to cutting-edge research and technology, allowing the company to work alongside leading minds in the biomaterials field. Research has been published in several renowned, prestigious journals.
- VISTA InstitutecoreSigmaGraft partners with VISTA Institute for dental education programs. Joint program on Management of Implant Functional and Esthetic Complications scheduled for July 11-12, 2026 in Woodland Hills, CA, featuring multiple clinicians and offering 16 CE units.
- EAO (European Association for Osseointegration)minorSigmaGraft Industry Forums at EAO Congress 2026 in Lisbon, Portugal featuring Dr. Hom-Lay Wang discussing advancements in bone regeneration and implant therapy.
Scale indicators3 records
Recent moves5 records
Expansion highlights5 records
SigmaGraft competitors and assessment
Company assessmentBroad incumbents
- Stryker: Stryker's orthobiologics portfolio includes Vitoss synthetic bone graft, OP-1 putty, and various allograft products. Comparable as a broad incumbent selling bone graft substitutes into orthopedic, spine, and trauma channels overlapping with SigmaGraft's orthopedic segment.
- Medtronic (Spine & Biologics): Through its Spine & Biologics division, Medtronic offers Infuse (rhBMP-2), Grafton DBM, and Mastergraft synthetic bone grafts. Directly comparable in orthopedic spine and trauma bone graft substitutes where SigmaGraft's AlloGen DBM and BoneSigma TCP compete.
- Zimmer Biomet: Major orthopedic and dental medical device company offering RegenerOss bone graft substitutes and dental implant solutions. Comparable because it sells allograft, xenograft, and synthetic bone grafts into the same dental and orthopedic surgical call points.
- Dentsply Sirona: Global dental equipment and consumables leader with bone graft substitute offerings (e.g., Symbios) and the largest installed base in dental practices. Comparable as a broad incumbent in the dental regenerative materials space.
Direct peers
- NovaBone Products: Specialist manufacturer of synthetic bioactive glass and calcium phosphate bone graft substitutes (NovaBone IRM, NovaBone Morsels). Direct peer for SigmaGraft's BoneSigma BCP/TCP ceramic lines in dental and orthopedic bone regeneration.
- Geistlich Pharma: The global leader in dental bone regeneration (Bio-Oss xenograft, Bio-Gide membrane). Direct peer with overlapping product portfolio in dental bone graft substitutes and resorbable collagen membranes serving periodontists, oral surgeons, and implantologists worldwide.
- Biomatlante: French specialist in synthetic bone graft substitutes (MBCP biphasic calcium phosphate). Direct peer for SigmaGraft's bioceramic bone substitutes with comparable technology positioning in dental and orthopedic bone regeneration.
- BioHorizons (Henry Schein): Dental implant company with a regeneration portfolio including MinerOss xenograft and allograft bone substitutes plus resorbable membranes. Direct peer in dental bone grafting and tissue regeneration products sold through the same implantology channel.
- ACE Surgical Supply: US-based dental surgical supply company offering bone graft materials, membranes, and regenerative products to periodontists and oral surgeons. Comparable mid-size peer with overlapping dental bone graft and tissue regeneration catalog.
Emerging players
- Collagen Matrix / Collagen Solutions: Specialist manufacturer of collagen-based medical devices including dental membranes and bone graft substitutes. Comparable as a focused player in the collagen/membrane niche where SigmaGraft's InterCollagen Guide competes.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
SigmaGraft social profiles
Digital presenceSigmaGraft compliance and trust
Trust signalCompliance1 record
SigmaGraft financial estimates
Financial estimateRevenue estimate
Valuation estimate
SigmaGraft leadership team
Management profileNumber of profiles
SigmaGraft funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SigmaGraft M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SigmaGraft
What does SigmaGraft do?
SigmaGraft manufactures and sells biomaterial products for bone and tissue regeneration, including allograft and xenograft bone substitutes, bone-collagen composites, synthetic biphasic and tricalcium phosphate bioceramics, resorbable collagen membranes, wound dressings, and surgical sutures. These products are used by dental professionals and orthopedic surgeons for guided bone regeneration, ridge preservation, dental implant placement, sinus augmentation, periodontal defect treatment, spinal fusion, trauma surgery, and sports medicine. The company also offers contract manufacturing services to other medical device companies using its ISO Class 7 facilities.
Is SigmaGraft a public or private company?
SigmaGraft is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was SigmaGraft founded?
SigmaGraft was founded in 2010. It employs 11 to 50 people.
Where is SigmaGraft based?
SigmaGraft is headquartered in Fullerton, United States, in the North America region.
How does SigmaGraft make money?
One revenue line is on record: biomaterial Products.
Who are SigmaGraft's main competitors?
Broad incumbents on record are Stryker, Medtronic (Spine & Biologics), Zimmer Biomet and Dentsply Sirona. Direct peers are NovaBone Products, Geistlich Pharma, Biomatlante, BioHorizons (Henry Schein) and ACE Surgical Supply. Collagen Matrix / Collagen Solutions is listed as an emerging player.
Does SigmaGraft have an API?
No public API is recorded for SigmaGraft.
What industry is SigmaGraft in?
SigmaGraft's product category is Medical Device Biomaterials. Its primary akta.pro industry code is HLAHAEAG, Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM), with a secondary code of HLAAAGAH, Cartilage, Bone & Musculoskeletal Regeneration. Its NAICS code is 339113 and its SIC code is 3842.